C9H10ClNOS, monoclinic, C2/c (no. 15), a=18.8783(6) Å, b=4.5518(2) Å, c=23.6739(8) Å, β=91.501(4)°, V =2033.61(13) Å3, Z =8, Rgt(F)=0.033, wRref(F2)=0.082, T =100(2) K
The molecular structure is shown in the figure. Tables 1 and 2, respectively, contain details on cr...
C12H15NO4, triclinic, P1̄ (no. 2), a = 5.0167(2) Å, b = 7.9264(5) Å, c = 15.2073(7) Å, α = 98.909(4)...
The geometric parameters of the title compound, Csb 11Hsb 10ClNOsb 2, are in the normal ranges. The ...
C10H12ClNOS, monoclinic, P21/n (no. 14), a=13.2003(12) Å, b=6.0448(6) Å, c=13.9403(13) Å, β=101.918...
C8H8ClNOS, triclinic, P¯1 (no. 2), a=6.7658(5) Å, b=8.0344(10) Å, c=9.6285(12) Å, α=66.279(12)°, β...
C11H15NOS, monoclinic, C2/c (no. 15), a = 21.0452(12) Å, b = 6.1447(4) Å, c = 17.1892(10) Å, β = 93...
C13H15Cl3N4Sn, monoclinic, C2/c (no. 15), a = 32.4593(4) Å, b = 7.43400(10) Å, c = 14.7108(2) Å, β ...
C11H11Cl2NO3, monoclinic, P21/c (no. 14), a = 17.2336(3) Å, b = 4.9604(1) Å, c = 14.3696(3) Å, β = 1...
The asymmetric unit of the title crystal structure is shown in the figure. Tables 1 and 2 contain de...
Abstract C13H17N3OS, triclinic, P1̄ (no. 2), a = 6.9906(9) Å, b = 8.0075(11) Å, c = 1...
C23H24ClN3O4Sn, triclinic, P (1) over bar (no. 2), a = 9.7536(2) angstrom, b = 10.0755(2) angstrom, ...
C23H24ClN3O4Sn, triclinic, P (1) over bar (no. 2), a = 9.7536(2) angstrom, b = 10.0755(2) angstrom, ...
C26H40AuFNOPS, triclinic, P1 (no. 1), a = 9.62498(7) Å, b = 11.78239(10) Å, c = 12.74349(13) Å, α = ...
C12H14N2O6, triclinic, P1̄ (no. 2), a = 4.8835(4) Å, b = 9.2111(7) Å, c = 14.6655(7) Å, α = 76.135(5...
C11H13Cl3O2Te, monoclinic, P21/c (no. 14), a = 11.0098(8) Å, b = 16.471(1) Å, c = 8.4975(7) Å, β = 9...
The molecular structure is shown in the figure. Tables 1 and 2, respectively, contain details on cr...
C12H15NO4, triclinic, P1̄ (no. 2), a = 5.0167(2) Å, b = 7.9264(5) Å, c = 15.2073(7) Å, α = 98.909(4)...
The geometric parameters of the title compound, Csb 11Hsb 10ClNOsb 2, are in the normal ranges. The ...
C10H12ClNOS, monoclinic, P21/n (no. 14), a=13.2003(12) Å, b=6.0448(6) Å, c=13.9403(13) Å, β=101.918...
C8H8ClNOS, triclinic, P¯1 (no. 2), a=6.7658(5) Å, b=8.0344(10) Å, c=9.6285(12) Å, α=66.279(12)°, β...
C11H15NOS, monoclinic, C2/c (no. 15), a = 21.0452(12) Å, b = 6.1447(4) Å, c = 17.1892(10) Å, β = 93...
C13H15Cl3N4Sn, monoclinic, C2/c (no. 15), a = 32.4593(4) Å, b = 7.43400(10) Å, c = 14.7108(2) Å, β ...
C11H11Cl2NO3, monoclinic, P21/c (no. 14), a = 17.2336(3) Å, b = 4.9604(1) Å, c = 14.3696(3) Å, β = 1...
The asymmetric unit of the title crystal structure is shown in the figure. Tables 1 and 2 contain de...
Abstract C13H17N3OS, triclinic, P1̄ (no. 2), a = 6.9906(9) Å, b = 8.0075(11) Å, c = 1...
C23H24ClN3O4Sn, triclinic, P (1) over bar (no. 2), a = 9.7536(2) angstrom, b = 10.0755(2) angstrom, ...
C23H24ClN3O4Sn, triclinic, P (1) over bar (no. 2), a = 9.7536(2) angstrom, b = 10.0755(2) angstrom, ...
C26H40AuFNOPS, triclinic, P1 (no. 1), a = 9.62498(7) Å, b = 11.78239(10) Å, c = 12.74349(13) Å, α = ...
C12H14N2O6, triclinic, P1̄ (no. 2), a = 4.8835(4) Å, b = 9.2111(7) Å, c = 14.6655(7) Å, α = 76.135(5...
C11H13Cl3O2Te, monoclinic, P21/c (no. 14), a = 11.0098(8) Å, b = 16.471(1) Å, c = 8.4975(7) Å, β = 9...
The molecular structure is shown in the figure. Tables 1 and 2, respectively, contain details on cr...
C12H15NO4, triclinic, P1̄ (no. 2), a = 5.0167(2) Å, b = 7.9264(5) Å, c = 15.2073(7) Å, α = 98.909(4)...
The geometric parameters of the title compound, Csb 11Hsb 10ClNOsb 2, are in the normal ranges. The ...
DOI
Add to ORKG